Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin vs Simvastatin/Ezetimibe on sdLDL-C in Hypercholesterolemia
NCT00932620Phase 4Completed
- Sponsor
- University of Ioannina
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by University of Ioannina. Primary endpoint: Small Dense Low-density Lipoprotein Cholesterol at 3 months. Started Jun 2009; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00932620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00932620.